Overview Rating

Good

Technicals Analysis

0100

Financials Analysis

0100

Avrobio Stock (NASDAQ:AVRO), Quotes and News Summary

Q: What sector and industry does Avrobio (AVRO) operate in?

Avrobio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Avrobio Stock (NASDAQ: AVRO) stock price, news, charts, stock research, profile.

Open	$1.259
Close	$1.250
Volume / Avg.	30.702K / 215.404K
Day Range	1.240 - 1.270
52 Wk Range	0.570 - 1.700
Market Cap	$56.110M
P/E Ratio	4.667
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	0.34%
Days to Cover	1.2

Recent News

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.

Lisa Levin

Why Avrobio Shares Are Rising Wednesday

AVROBIO Inc (NASDAQ: AVRO) shares are trading higher Wednesday after the company said it will explore strategic alternatives.

Adam Eckert

Avrobio Stock Jumps On Sale Of Gene Therapy Program To Novartis

Shares of clinical-stage gene therapy company AVROBIO, Inc. (NASDAQ: AVRO) are trading higher Monday due to its agreement to sell its investigational hematopoietic stem cell (HSC) gene therapy program for the treatment of cystinosis

Ryan Gustafson

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Avrobio (AVRO) stock?

You can purchase shares of Avrobio (NASDAQ: AVRO) through any online brokerage.

View our list of the best stock brokerages.

Who are Avrobio's (AVRO) competitors?

Other companies in Avrobio’s space includes: Kezar Life Sciences (NASDAQ:KZR), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS), Eagle Pharmaceuticals (NASDAQ:EGRX) and Immuneering (NASDAQ:IMRX).

What is the target price for Avrobio (AVRO) stock?

The latest price target for Avrobio (NASDAQ: AVRO) was reported by Mizuho on Monday, December 18, 2023. The analyst firm set a price target for 2.00 expecting AVRO to rise to within 12 months (a possible 60.00% upside). 3 analyst firms have reported ratings in the last year.

Current Stock Price for Avrobio (AVRO)?

The stock price for Avrobio (NASDAQ: AVRO) is $1.25 last updated Today at May 9, 2024 at 5:21 PM EDT.

Does Avrobio (AVRO) pay a dividend?

There are no upcoming dividends for Avrobio.

When is Avrobio (NASDAQ:AVRO) reporting earnings?

Avrobio’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Is Avrobio (AVRO) going to split?

There is no upcoming split for Avrobio.

What sector and industry does Avrobio (AVRO) operate in?

Avrobio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-